Global Novel Drug Delivery Systems Market Growth (Status and Outlook) 2025-2031

March 2025 | 156 pages | ID: GDACCE60BA42EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Novel Drug Delivery Systems market size is predicted to grow from US$ 24960 million in 2025 to US$ 27720 million in 2031; it is expected to grow at a CAGR of 1.8% from 2025 to 2031.

Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.

Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.

Global Novel Drug Delivery Systems key players include Amgen, Teva, Roche, UCB (Union Chimique Belge), etc. Global top four manufacturers hold a share over 40%.

North America is the largest market, with a share about 50%, followed by Asia-Pacific and Europe, both have a share over 40 percent.

In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%. And in terms of application, the largest application is Hospitals & Clinic, followed by Cancer Treatment Centers, etc.

LPI (LP Information)' newest research report, the “Novel Drug Delivery Systems Industry Forecast” looks at past sales and reviews total world Novel Drug Delivery Systems sales in 2024, providing a comprehensive analysis by region and market sector of projected Novel Drug Delivery Systems sales for 2025 through 2031. With Novel Drug Delivery Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Novel Drug Delivery Systems industry.

This Insight Report provides a comprehensive analysis of the global Novel Drug Delivery Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Novel Drug Delivery Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Novel Drug Delivery Systems market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Novel Drug Delivery Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Novel Drug Delivery Systems.

This report presents a comprehensive overview, market shares, and growth opportunities of Novel Drug Delivery Systems market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Liposomes
• PEGylated Proteins & Polypeptides
• Polymer Nanoparticle
• Protein–drug Conjugates
• Others

Segmentation by Application:

• Hospitals & Clinic
• Cancer Treatment Centers
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Amgen
• Teva
• Roche
• UCB (Union Chimique Belge)
• Celgene
• Merck
• Gilead Sciences
• Sanofi
• Pfizer
• Takeda
• Bausch&Lomb
• Samyang Biopharmaceuticals
• Johnson & Johnson
• TOLMAR
• Astellas
• AMAG Pharmaceuticals
• AbbVie
• Dr Reddy
• AstraZeneca
• Aspen
• Acrotech Biopharma
• TWi Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Novel Drug Delivery Systems Market Size (2020-2031)
  2.1.2 Novel Drug Delivery Systems Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Novel Drug Delivery Systems by Country/Region (2020, 2024 & 2031)
2.2 Novel Drug Delivery Systems Segment by Type
  2.2.1 Liposomes
  2.2.2 PEGylated Proteins & Polypeptides
  2.2.3 Polymer Nanoparticle
  2.2.4 Protein–drug Conjugates
  2.2.5 Others
2.3 Novel Drug Delivery Systems Market Size by Type
  2.3.1 Novel Drug Delivery Systems Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Novel Drug Delivery Systems Market Size Market Share by Type (2020-2025)
2.4 Novel Drug Delivery Systems Segment by Application
  2.4.1 Hospitals & Clinic
  2.4.2 Cancer Treatment Centers
  2.4.3 Others
2.5 Novel Drug Delivery Systems Market Size by Application
  2.5.1 Novel Drug Delivery Systems Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Novel Drug Delivery Systems Market Size Market Share by Application (2020-2025)

3 NOVEL DRUG DELIVERY SYSTEMS MARKET SIZE BY PLAYER

3.1 Novel Drug Delivery Systems Market Size Market Share by Player
  3.1.1 Global Novel Drug Delivery Systems Revenue by Player (2020-2025)
  3.1.2 Global Novel Drug Delivery Systems Revenue Market Share by Player (2020-2025)
3.2 Global Novel Drug Delivery Systems Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NOVEL DRUG DELIVERY SYSTEMS BY REGION

4.1 Novel Drug Delivery Systems Market Size by Region (2020-2025)
4.2 Global Novel Drug Delivery Systems Annual Revenue by Country/Region (2020-2025)
4.3 Americas Novel Drug Delivery Systems Market Size Growth (2020-2025)
4.4 APAC Novel Drug Delivery Systems Market Size Growth (2020-2025)
4.5 Europe Novel Drug Delivery Systems Market Size Growth (2020-2025)
4.6 Middle East & Africa Novel Drug Delivery Systems Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Novel Drug Delivery Systems Market Size by Country (2020-2025)
5.2 Americas Novel Drug Delivery Systems Market Size by Type (2020-2025)
5.3 Americas Novel Drug Delivery Systems Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Novel Drug Delivery Systems Market Size by Region (2020-2025)
6.2 APAC Novel Drug Delivery Systems Market Size by Type (2020-2025)
6.3 APAC Novel Drug Delivery Systems Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Novel Drug Delivery Systems Market Size by Country (2020-2025)
7.2 Europe Novel Drug Delivery Systems Market Size by Type (2020-2025)
7.3 Europe Novel Drug Delivery Systems Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Novel Drug Delivery Systems by Region (2020-2025)
8.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Type (2020-2025)
8.3 Middle East & Africa Novel Drug Delivery Systems Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET FORECAST

10.1 Global Novel Drug Delivery Systems Forecast by Region (2026-2031)
  10.1.1 Global Novel Drug Delivery Systems Forecast by Region (2026-2031)
  10.1.2 Americas Novel Drug Delivery Systems Forecast
  10.1.3 APAC Novel Drug Delivery Systems Forecast
  10.1.4 Europe Novel Drug Delivery Systems Forecast
  10.1.5 Middle East & Africa Novel Drug Delivery Systems Forecast
10.2 Americas Novel Drug Delivery Systems Forecast by Country (2026-2031)
  10.2.1 United States Market Novel Drug Delivery Systems Forecast
  10.2.2 Canada Market Novel Drug Delivery Systems Forecast
  10.2.3 Mexico Market Novel Drug Delivery Systems Forecast
  10.2.4 Brazil Market Novel Drug Delivery Systems Forecast
10.3 APAC Novel Drug Delivery Systems Forecast by Region (2026-2031)
  10.3.1 China Novel Drug Delivery Systems Market Forecast
  10.3.2 Japan Market Novel Drug Delivery Systems Forecast
  10.3.3 Korea Market Novel Drug Delivery Systems Forecast
  10.3.4 Southeast Asia Market Novel Drug Delivery Systems Forecast
  10.3.5 India Market Novel Drug Delivery Systems Forecast
  10.3.6 Australia Market Novel Drug Delivery Systems Forecast
10.4 Europe Novel Drug Delivery Systems Forecast by Country (2026-2031)
  10.4.1 Germany Market Novel Drug Delivery Systems Forecast
  10.4.2 France Market Novel Drug Delivery Systems Forecast
  10.4.3 UK Market Novel Drug Delivery Systems Forecast
  10.4.4 Italy Market Novel Drug Delivery Systems Forecast
  10.4.5 Russia Market Novel Drug Delivery Systems Forecast
10.5 Middle East & Africa Novel Drug Delivery Systems Forecast by Region (2026-2031)
  10.5.1 Egypt Market Novel Drug Delivery Systems Forecast
  10.5.2 South Africa Market Novel Drug Delivery Systems Forecast
  10.5.3 Israel Market Novel Drug Delivery Systems Forecast
  10.5.4 Turkey Market Novel Drug Delivery Systems Forecast
10.6 Global Novel Drug Delivery Systems Forecast by Type (2026-2031)
10.7 Global Novel Drug Delivery Systems Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Novel Drug Delivery Systems Forecast

11 KEY PLAYERS ANALYSIS

11.1 Amgen
  11.1.1 Amgen Company Information
  11.1.2 Amgen Novel Drug Delivery Systems Product Offered
  11.1.3 Amgen Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Amgen Main Business Overview
  11.1.5 Amgen Latest Developments
11.2 Teva
  11.2.1 Teva Company Information
  11.2.2 Teva Novel Drug Delivery Systems Product Offered
  11.2.3 Teva Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Teva Main Business Overview
  11.2.5 Teva Latest Developments
11.3 Roche
  11.3.1 Roche Company Information
  11.3.2 Roche Novel Drug Delivery Systems Product Offered
  11.3.3 Roche Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Roche Main Business Overview
  11.3.5 Roche Latest Developments
11.4 UCB (Union Chimique Belge)
  11.4.1 UCB (Union Chimique Belge) Company Information
  11.4.2 UCB (Union Chimique Belge) Novel Drug Delivery Systems Product Offered
  11.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 UCB (Union Chimique Belge) Main Business Overview
  11.4.5 UCB (Union Chimique Belge) Latest Developments
11.5 Celgene
  11.5.1 Celgene Company Information
  11.5.2 Celgene Novel Drug Delivery Systems Product Offered
  11.5.3 Celgene Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Celgene Main Business Overview
  11.5.5 Celgene Latest Developments
11.6 Merck
  11.6.1 Merck Company Information
  11.6.2 Merck Novel Drug Delivery Systems Product Offered
  11.6.3 Merck Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Merck Main Business Overview
  11.6.5 Merck Latest Developments
11.7 Gilead Sciences
  11.7.1 Gilead Sciences Company Information
  11.7.2 Gilead Sciences Novel Drug Delivery Systems Product Offered
  11.7.3 Gilead Sciences Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Gilead Sciences Main Business Overview
  11.7.5 Gilead Sciences Latest Developments
11.8 Sanofi
  11.8.1 Sanofi Company Information
  11.8.2 Sanofi Novel Drug Delivery Systems Product Offered
  11.8.3 Sanofi Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Sanofi Main Business Overview
  11.8.5 Sanofi Latest Developments
11.9 Pfizer
  11.9.1 Pfizer Company Information
  11.9.2 Pfizer Novel Drug Delivery Systems Product Offered
  11.9.3 Pfizer Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Pfizer Main Business Overview
  11.9.5 Pfizer Latest Developments
11.10 Takeda
  11.10.1 Takeda Company Information
  11.10.2 Takeda Novel Drug Delivery Systems Product Offered
  11.10.3 Takeda Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Takeda Main Business Overview
  11.10.5 Takeda Latest Developments
11.11 Bausch&Lomb
  11.11.1 Bausch&Lomb Company Information
  11.11.2 Bausch&Lomb Novel Drug Delivery Systems Product Offered
  11.11.3 Bausch&Lomb Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Bausch&Lomb Main Business Overview
  11.11.5 Bausch&Lomb Latest Developments
11.12 Samyang Biopharmaceuticals
  11.12.1 Samyang Biopharmaceuticals Company Information
  11.12.2 Samyang Biopharmaceuticals Novel Drug Delivery Systems Product Offered
  11.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Samyang Biopharmaceuticals Main Business Overview
  11.12.5 Samyang Biopharmaceuticals Latest Developments
11.13 Johnson & Johnson
  11.13.1 Johnson & Johnson Company Information
  11.13.2 Johnson & Johnson Novel Drug Delivery Systems Product Offered
  11.13.3 Johnson & Johnson Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Johnson & Johnson Main Business Overview
  11.13.5 Johnson & Johnson Latest Developments
11.14 TOLMAR
  11.14.1 TOLMAR Company Information
  11.14.2 TOLMAR Novel Drug Delivery Systems Product Offered
  11.14.3 TOLMAR Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 TOLMAR Main Business Overview
  11.14.5 TOLMAR Latest Developments
11.15 Astellas
  11.15.1 Astellas Company Information
  11.15.2 Astellas Novel Drug Delivery Systems Product Offered
  11.15.3 Astellas Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Astellas Main Business Overview
  11.15.5 Astellas Latest Developments
11.16 AMAG Pharmaceuticals
  11.16.1 AMAG Pharmaceuticals Company Information
  11.16.2 AMAG Pharmaceuticals Novel Drug Delivery Systems Product Offered
  11.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 AMAG Pharmaceuticals Main Business Overview
  11.16.5 AMAG Pharmaceuticals Latest Developments
11.17 AbbVie
  11.17.1 AbbVie Company Information
  11.17.2 AbbVie Novel Drug Delivery Systems Product Offered
  11.17.3 AbbVie Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.17.4 AbbVie Main Business Overview
  11.17.5 AbbVie Latest Developments
11.18 Dr Reddy
  11.18.1 Dr Reddy Company Information
  11.18.2 Dr Reddy Novel Drug Delivery Systems Product Offered
  11.18.3 Dr Reddy Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.18.4 Dr Reddy Main Business Overview
  11.18.5 Dr Reddy Latest Developments
11.19 AstraZeneca
  11.19.1 AstraZeneca Company Information
  11.19.2 AstraZeneca Novel Drug Delivery Systems Product Offered
  11.19.3 AstraZeneca Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.19.4 AstraZeneca Main Business Overview
  11.19.5 AstraZeneca Latest Developments
11.20 Aspen
  11.20.1 Aspen Company Information
  11.20.2 Aspen Novel Drug Delivery Systems Product Offered
  11.20.3 Aspen Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.20.4 Aspen Main Business Overview
  11.20.5 Aspen Latest Developments
11.21 Acrotech Biopharma
  11.21.1 Acrotech Biopharma Company Information
  11.21.2 Acrotech Biopharma Novel Drug Delivery Systems Product Offered
  11.21.3 Acrotech Biopharma Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.21.4 Acrotech Biopharma Main Business Overview
  11.21.5 Acrotech Biopharma Latest Developments
11.22 TWi Pharmaceuticals
  11.22.1 TWi Pharmaceuticals Company Information
  11.22.2 TWi Pharmaceuticals Novel Drug Delivery Systems Product Offered
  11.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
  11.22.4 TWi Pharmaceuticals Main Business Overview
  11.22.5 TWi Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Novel Drug Delivery Systems Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Novel Drug Delivery Systems Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liposomes
Table 4. Major Players of PEGylated Proteins & Polypeptides
Table 5. Major Players of Polymer Nanoparticle
Table 6. Major Players of Protein–drug Conjugates
Table 7. Major Players of Others
Table 8. Novel Drug Delivery Systems Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Novel Drug Delivery Systems Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Novel Drug Delivery Systems Market Size Market Share by Type (2020-2025)
Table 11. Novel Drug Delivery Systems Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Novel Drug Delivery Systems Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Novel Drug Delivery Systems Market Size Market Share by Application (2020-2025)
Table 14. Global Novel Drug Delivery Systems Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Novel Drug Delivery Systems Revenue Market Share by Player (2020-2025)
Table 16. Novel Drug Delivery Systems Key Players Head office and Products Offered
Table 17. Novel Drug Delivery Systems Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Novel Drug Delivery Systems Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Novel Drug Delivery Systems Market Size Market Share by Region (2020-2025)
Table 22. Global Novel Drug Delivery Systems Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Novel Drug Delivery Systems Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Novel Drug Delivery Systems Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Novel Drug Delivery Systems Market Size Market Share by Country (2020-2025)
Table 26. Americas Novel Drug Delivery Systems Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Novel Drug Delivery Systems Market Size Market Share by Type (2020-2025)
Table 28. Americas Novel Drug Delivery Systems Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Novel Drug Delivery Systems Market Size Market Share by Application (2020-2025)
Table 30. APAC Novel Drug Delivery Systems Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Novel Drug Delivery Systems Market Size Market Share by Region (2020-2025)
Table 32. APAC Novel Drug Delivery Systems Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Novel Drug Delivery Systems Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Novel Drug Delivery Systems Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Novel Drug Delivery Systems Market Size Market Share by Country (2020-2025)
Table 36. Europe Novel Drug Delivery Systems Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Novel Drug Delivery Systems Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Novel Drug Delivery Systems Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Novel Drug Delivery Systems Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Novel Drug Delivery Systems Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Novel Drug Delivery Systems
Table 42. Key Market Challenges & Risks of Novel Drug Delivery Systems
Table 43. Key Industry Trends of Novel Drug Delivery Systems
Table 44. Global Novel Drug Delivery Systems Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Novel Drug Delivery Systems Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Novel Drug Delivery Systems Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Novel Drug Delivery Systems Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Amgen Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 49. Amgen Novel Drug Delivery Systems Product Offered
Table 50. Amgen Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Amgen Main Business
Table 52. Amgen Latest Developments
Table 53. Teva Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 54. Teva Novel Drug Delivery Systems Product Offered
Table 55. Teva Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Teva Main Business
Table 57. Teva Latest Developments
Table 58. Roche Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 59. Roche Novel Drug Delivery Systems Product Offered
Table 60. Roche Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Roche Main Business
Table 62. Roche Latest Developments
Table 63. UCB (Union Chimique Belge) Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 64. UCB (Union Chimique Belge) Novel Drug Delivery Systems Product Offered
Table 65. UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. UCB (Union Chimique Belge) Main Business
Table 67. UCB (Union Chimique Belge) Latest Developments
Table 68. Celgene Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 69. Celgene Novel Drug Delivery Systems Product Offered
Table 70. Celgene Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Celgene Main Business
Table 72. Celgene Latest Developments
Table 73. Merck Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 74. Merck Novel Drug Delivery Systems Product Offered
Table 75. Merck Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. Gilead Sciences Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 79. Gilead Sciences Novel Drug Delivery Systems Product Offered
Table 80. Gilead Sciences Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Gilead Sciences Main Business
Table 82. Gilead Sciences Latest Developments
Table 83. Sanofi Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 84. Sanofi Novel Drug Delivery Systems Product Offered
Table 85. Sanofi Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. Pfizer Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 89. Pfizer Novel Drug Delivery Systems Product Offered
Table 90. Pfizer Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Takeda Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 94. Takeda Novel Drug Delivery Systems Product Offered
Table 95. Takeda Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Takeda Main Business
Table 97. Takeda Latest Developments
Table 98. Bausch&Lomb Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 99. Bausch&Lomb Novel Drug Delivery Systems Product Offered
Table 100. Bausch&Lomb Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. Bausch&Lomb Main Business
Table 102. Bausch&Lomb Latest Developments
Table 103. Samyang Biopharmaceuticals Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 104. Samyang Biopharmaceuticals Novel Drug Delivery Systems Product Offered
Table 105. Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. Samyang Biopharmaceuticals Main Business
Table 107. Samyang Biopharmaceuticals Latest Developments
Table 108. Johnson & Johnson Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 109. Johnson & Johnson Novel Drug Delivery Systems Product Offered
Table 110. Johnson & Johnson Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. Johnson & Johnson Main Business
Table 112. Johnson & Johnson Latest Developments
Table 113. TOLMAR Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 114. TOLMAR Novel Drug Delivery Systems Product Offered
Table 115. TOLMAR Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. TOLMAR Main Business
Table 117. TOLMAR Latest Developments
Table 118. Astellas Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 119. Astellas Novel Drug Delivery Systems Product Offered
Table 120. Astellas Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 121. Astellas Main Business
Table 122. Astellas Latest Developments
Table 123. AMAG Pharmaceuticals Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 124. AMAG Pharmaceuticals Novel Drug Delivery Systems Product Offered
Table 125. AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 126. AMAG Pharmaceuticals Main Business
Table 127. AMAG Pharmaceuticals Latest Developments
Table 128. AbbVie Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 129. AbbVie Novel Drug Delivery Systems Product Offered
Table 130. AbbVie Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 131. AbbVie Main Business
Table 132. AbbVie Latest Developments
Table 133. Dr Reddy Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 134. Dr Reddy Novel Drug Delivery Systems Product Offered
Table 135. Dr Reddy Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 136. Dr Reddy Main Business
Table 137. Dr Reddy Latest Developments
Table 138. AstraZeneca Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 139. AstraZeneca Novel Drug Delivery Systems Product Offered
Table 140. AstraZeneca Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 141. AstraZeneca Main Business
Table 142. AstraZeneca Latest Developments
Table 143. Aspen Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 144. Aspen Novel Drug Delivery Systems Product Offered
Table 145. Aspen Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 146. Aspen Main Business
Table 147. Aspen Latest Developments
Table 148. Acrotech Biopharma Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 149. Acrotech Biopharma Novel Drug Delivery Systems Product Offered
Table 150. Acrotech Biopharma Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 151. Acrotech Biopharma Main Business
Table 152. Acrotech Biopharma Latest Developments
Table 153. TWi Pharmaceuticals Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 154. TWi Pharmaceuticals Novel Drug Delivery Systems Product Offered
Table 155. TWi Pharmaceuticals Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 156. TWi Pharmaceuticals Main Business
Table 157. TWi Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Novel Drug Delivery Systems Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Novel Drug Delivery Systems Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Novel Drug Delivery Systems Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Novel Drug Delivery Systems Sales Market Share by Country/Region (2024)
Figure 8. Novel Drug Delivery Systems Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Novel Drug Delivery Systems Market Size Market Share by Type in 2024
Figure 10. Novel Drug Delivery Systems in Hospitals & Clinic
Figure 11. Global Novel Drug Delivery Systems Market: Hospitals & Clinic (2020-2025) & ($ millions)
Figure 12. Novel Drug Delivery Systems in Cancer Treatment Centers
Figure 13. Global Novel Drug Delivery Systems Market: Cancer Treatment Centers (2020-2025) & ($ millions)
Figure 14. Novel Drug Delivery Systems in Others
Figure 15. Global Novel Drug Delivery Systems Market: Others (2020-2025) & ($ millions)
Figure 16. Global Novel Drug Delivery Systems Market Size Market Share by Application in 2024
Figure 17. Global Novel Drug Delivery Systems Revenue Market Share by Player in 2024
Figure 18. Global Novel Drug Delivery Systems Market Size Market Share by Region (2020-2025)
Figure 19. Americas Novel Drug Delivery Systems Market Size 2020-2025 ($ millions)
Figure 20. APAC Novel Drug Delivery Systems Market Size 2020-2025 ($ millions)
Figure 21. Europe Novel Drug Delivery Systems Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Novel Drug Delivery Systems Market Size 2020-2025 ($ millions)
Figure 23. Americas Novel Drug Delivery Systems Value Market Share by Country in 2024
Figure 24. United States Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Novel Drug Delivery Systems Market Size Market Share by Region in 2024
Figure 29. APAC Novel Drug Delivery Systems Market Size Market Share by Type (2020-2025)
Figure 30. APAC Novel Drug Delivery Systems Market Size Market Share by Application (2020-2025)
Figure 31. China Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 35. India Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Novel Drug Delivery Systems Market Size Market Share by Country in 2024
Figure 38. Europe Novel Drug Delivery Systems Market Size Market Share by Type (2020-2025)
Figure 39. Europe Novel Drug Delivery Systems Market Size Market Share by Application (2020-2025)
Figure 40. Germany Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 41. France Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Novel Drug Delivery Systems Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Novel Drug Delivery Systems Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Novel Drug Delivery Systems Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Novel Drug Delivery Systems Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 54. APAC Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 55. Europe Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 57. United States Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 58. Canada Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 59. Mexico Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 60. Brazil Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 61. China Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 62. Japan Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 63. Korea Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 65. India Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 66. Australia Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 67. Germany Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 68. France Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 69. UK Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 70. Italy Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 71. Russia Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 72. Egypt Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 73. South Africa Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 74. Israel Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 75. Turkey Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)
Figure 76. Global Novel Drug Delivery Systems Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Novel Drug Delivery Systems Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Novel Drug Delivery Systems Market Size 2026-2031 ($ millions)